Remdesivir

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Rockville, December 02, 2021: Emmes today announced that it conducted the data and statistical analysis for the third iteration of…

2 years ago

FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19

This novel technology using green chemistry provides a sustainable, efficient and scalable form of treatment  to fight against COVID 19   New…

3 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420